Product Description
Since last manyyears Saintroy Lifescience is leading manufacture, export and supplierofDocetaxel Injectionfrom Surat, Gujarat, India. Docetaxel Injection used in the treatment of various cancers, including breast, lung,prostate, gastric, head and neck, and ovarian cancer.
Tags: Docetaxel Injection manufacturer, Docetaxel Injection exporter,Docetaxel Injection supplier, and Docetaxel Injection, whogmp approved Docetaxel Injectionmanufacturer and supplier, Docetaxel Injection distributor, Docetaxel Injectionshipper, Docetaxel Injection20 mgDocetaxel Injection 20 mg supplier,Docetaxel Injection20 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility inGujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTorCTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Docetaxel Injection export toUSA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Versatile Cancer TherapyDocetaxel Injection 80 mg is designed for broad oncological applications, treating several types of cancers such as breast, non-small cell lung, prostate, gastric, and head and neck cancers. Its effectiveness is supported by established protocols and it is compatible with standard infusion systems, assuring reliability in clinical settings.
Convenient Packaging and HandlingEach glass vial features a secure rubber stopper and comes individually boxed, maintaining sterility and facilitating safe handling. The inclusion of ethanol and polysorbate 80 as solvents ensures quick preparation for infusion when diluted as per the manufacturer's guidelines.
Quality and Storage AssuranceDocetaxel Injection is delivered as a clear solution, free of particulates, and must be stored in a cool, dry place. Detailed batch and expiry information is printed on both the vial and the carton, adhering to regulatory and quality standards required in distribution and export.
FAQ's of Docetaxel Injection:
Q: How should Docetaxel Injection 80 mg be administered?
A: Docetaxel Injection must be diluted as per the manufacturer's guidelines and administered exclusively by intravenous infusion over a specified duration by qualified healthcare professionals.
Q: What is the correct process to prepare Docetaxel Injection for use?
A: After confirming the batch number and expiry, the content of the vial should be diluted using the provided solvents (ethanol and polysorbate 80) as instructed by the manufacturer, followed by further dilution with intravenous fluids prior to infusion.
Q: When is Docetaxel Injection indicated for treatment?
A: This injection is prescribed for patients diagnosed with breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, or head and neck cancer, as determined appropriate by an oncologist.
Q: Where should Docetaxel Injection be stored before use?
A: Store Docetaxel Injection in a cool and dry place, as high temperatures and humidity may affect its stability and efficacy.
Q: What safety measures should be taken when handling or administering the medication?
A: Use standard safety protocols for cytotoxic drugs, wear appropriate protective equipment, and ensure the solution is clear and free of particulates before administration.
Q: What are the benefits of Docetaxel Injection for cancer treatment?
A: Docetaxel has demonstrated significant therapeutic potential to slow cancer cell growth and improve patient outcomes across multiple cancer types, especially when used according to recommended protocols.
Q: Is there a specific appearance or smell I should expect from the solution?
A: The solution should appear clear to slightly yellow without visible particulates and has a normal, mild fermentation smell due to its composition.